Search

2665 Results for "Cancer"

Endocrine Society, March 20-23

The annual meeting of the Endocrine Society was held virtually this year from March 20 to 23 and attracted participants from around the world, including clinicians, academicians, allied health professionals, and others interested in endocrine and metabolic disorders. The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, growth hormone,...

Pomalidomide-Based Regimen for Newly Diagnosed Multiple Myeloma

Pomalidomide, bortezomib, and dexamethasone combination chemotherapy is efficacious and safe for the treatment of newly diagnosed multiple myeloma. Multiple myeloma (MM) is an incurable disease. Currently, treatment aims to improve the quality of life and overall survival of these patients. The established standard treatment in newly diagnosed multiple myeloma (NDMM) cases consists of bortezomib, lenalidomide,...

Benefits of Exercise and Diet Therapy for HIV/AIDS Patients

Exercise training and diet therapy improved physical fitness and salivary testosterone levels in an interventional study of people living with HIV/AIDS. Acquired immune deficiency syndrome (AIDS) is caused by the human immunodeficiency virus (HIV). Exercise and nutrition constitute important components of treatment protocols and rehabilitation care for people living with HIV/AIDS (PLWHA). However, no thorough...

Narrowband UV-B Phototherapy: A Promising Treatment for Vitiligo in Children

Medically reviewed by Dr. Samuel Sarmiento, M.D., MPH on August 3, 2023 Insights from a recent study show the effectiveness and safety of narrowband UV-B phototherapy for children with vitiligo. If you’re a parent or caregiver of a child with vitiligo, this may offer some helpful information on this treatment option. Narrowband UV-B phototherapy can...

Quality of Life Improved With Physical Activity in Multiple Myeloma Patients

Physical activity data from patients with multiple myeloma revealed increases in activity after chemotherapy in older patients. Despite multiple myeloma causing pain related to movement, tracking patient activity using digital health technology applications proved valuable in disease management. Multiple myeloma can cause pain related to movement. Tracking patient activity using digital health technology applications is...

Dr. Valerie Harvey on her Vitiligo Treatment Strategy

In this MD Newsline exclusive interview with dermatologist Dr. Valerie Harvey, we discuss Dr. Harvey’s vitiligo treatment strategy. MD Newsline: What is your treatment strategy for vitiligo, and how is it tailored to each patient?  Dr. Valerie Harvey: “Which treatment I use for vitiligo depends on how much of the patient’s skin is affected by...

Screening for Social Determinants of Sickle Cell Disease

Social determinants of health are socioeconomic factors that can influence health outcomes. Patients with sickle cell disease (SCD) are disproportionately affected by negative social determinants. This study, published in Pediatric Blood & Cancer, focuses on the impact of a screening and referral program in addressing social determinants of health in children with SCD.  The screening protocol...

Drop in LDL Cholesterol Greater With Low-, Moderate-Intensity Statins for Seniors

Initiators of statins aged 75 years or older had higher mean percentage reduction than those younger than 50 years. For older versus younger adults, low- to moderate-intensity statins are associated with a greater reduction in low-density lipoprotein cholesterol (LDL-C), according to a study published online Aug. 1 in the Annals of Internal Medicine. Giulia Corn, Ph.D.,...

First Real-World Outcomes of Brentuximab Vedotin plus Nivolumab in CHL

Classical Hodgkin lymphoma (CHL) affects approximately 8,500 new patients each year, and the initial remission rate is over 80%. Previous studies have shown that brentuximab vedotin (BV) and nivolumab (Nivo) are well-tolerated and effective in treating relapsed or refractory (R/R) CHL, but no real-world data are available for this combination of treatments. This study, published...

Dr. Mohiba Tareen on Disparities in Atopic Dermatitis

Dr. Mohiba Tareen is a nationally acclaimed board certified dermatologist and Founder and Medical Director of Tareen Dermatology. With three locations and over 100 staff, Dr. Tareen and her team provide cutting-edge yet caring dermatologic care to patients. As an expert dermatologist for WebMD and WikiHow, Dr. Tareen is frequently interviewed by the media for...
<< >>

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.